Fig. 2From: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccineCellular immunity from splenocyte after stimulation. a–c IL-2 levels from mice vaccinated with rM1H, rM3H, MMH and PBS and challenged with A549 (a), HepG2 (b) and HHCC (c) cells. d–f IFN-γ levels from mice vaccinated with rM1H, rM3H, MMH and PBS and challenged with A549 (d), HepG2 (e) and HHCC (f) cellsBack to article page